{"corpus_id":6101497,"paper_sha":"d348549cf1ca63132ca2791a84265c1853b244aa","doi":"10.1093/BRAIN/112.1.133","arxiv_id":null,"pmid":2917275,"pmcid":null,"mag_id":1975104912,"dblp_id":null,"acl_id":null,"title":"The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.","year":1989,"publication_date":"1989-02-01","venue":"Brain : a journal of neurology","journal":{"name":"Brain : a journal of neurology","pages":"\n          133-46\n        ","volume":"112 ( Pt 1)"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle","Review"],"pubmed_pub_types":["Journal Article"],"s2_fields_of_study":["Medicine"],"reference_count":0,"citation_count":1630,"influential_citation_count":46,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Canada","mj":false,"ui":"D002170"},{"d":"Demography","mj":false,"ui":"D003710"},{"d":"Disability Evaluation","mj":false,"ui":"D004185"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Longitudinal Studies","mj":false,"ui":"D008137"},{"d":"Multiple Sclerosis","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"},{"q":"epidemiology","mj":true,"ui":"Q000453"},{"q":"mortality","mj":false,"ui":"Q000401"}],"ui":"D009103"},{"d":"Population Surveillance","mj":false,"ui":"D011159"}],"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://academic.oup.com/brain/article-pdf/112/1/133/1042303/112-1-133.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/d348549cf1ca63132ca2791a84265c1853b244aa","s2_open_access_license":null,"s2_open_access_status":"BRONZE","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"The outcome of multiple sclerosis (MS), assessed according to the Kurtzke Disability Status Scale (DSS), was reviewed in 1,099 consecutive patients followed in London, Canada, between 1972 and 1984. A geographically based subgroup of 196 patients representing 90% of Middlesex County MS patients as well as a group of 197 patients seen from onset of disease were separately analysed. The clinical course was progressive from onset in 33% of the total population and in 28% of the Middlesex County subgroup. Of those with duration of 6-10 yrs, 30-40% with initially remitting disease developed progressive MS. The cross-sectional distribution of disability was bimodal with peaks at DSS 1 (no disability) and DSS 6 (assistance required for walking). Actuarial analysis showed that the median time to reach DSS 6 from onset of MS was 14.97 +/- 0.31 yrs in the total population and 9.42 +/- 0.44 yrs in the \"seen from onset' subgroup. Survival was minimally altered; 87% of patients followed up to 40 yrs were still alive, although ascertainment of cases with this duration of MS was incomplete. Data describing the rate at which disability develops after the onset of a progressive phase of MS are also presented. The implications of these data in planning and interpretation of clinical therapeutic trials are discussed.","claims":[{"public_id":"cl_db77752d7f7661afed4e87a4171e9023","status":"active","text":"Among patients with 6-10 years of disease duration, 30-40% with initially remitting disease developed progressive multiple sclerosis.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_db77752d7f7661afed4e87a4171e9023"},{"public_id":"cl_05f4f2619914eb45b2e13c2311ac6aa5","status":"active","text":"Multiple sclerosis was progressive from onset in 33% of the total population and 28% of the Middlesex County subgroup.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_05f4f2619914eb45b2e13c2311ac6aa5"},{"public_id":"cl_7fe0f9894667b5a4c8d3564307ac3525","status":"active","text":"Survival was minimally altered, with 87% of patients followed up to 40 years still alive, although ascertainment of cases with that duration was incomplete.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_7fe0f9894667b5a4c8d3564307ac3525"},{"public_id":"cl_27aada03f406e5be56a1fab652dd64fd","status":"active","text":"The cross-sectional distribution of disability was bimodal, with peaks at DSS 1 and DSS 6.","confidence":0.99,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_27aada03f406e5be56a1fab652dd64fd"},{"public_id":"cl_12f91770f9e46182bcc1967174a3f368","status":"active","text":"The median time to reach DSS 6 from onset of multiple sclerosis was 14.97 +/- 0.31 years in the total population and 9.42 +/- 0.44 years in the seen-from-onset subgroup.","confidence":0.99,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_12f91770f9e46182bcc1967174a3f368"}],"concepts":[{"public_id":"co_0fefd8c128729ad5f8194acb405e9849","status":"active","name":"seen-from-onset subgroup","description":"The group of patients observed from the onset of disease.","types":["patient subgroup"],"aliases":["seen from onset subgroup"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0fefd8c128729ad5f8194acb405e9849"},{"public_id":"co_188350805249a459e68410be979cf524","status":"active","name":"DSS 1","description":"A Kurtzke Disability Status Scale level indicating no disability.","types":["measurement level"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_188350805249a459e68410be979cf524"},{"public_id":"co_48d7a64a40c8f34a5d1450fbda3c95ad","status":"active","name":"progressive multiple sclerosis","description":"A form of multiple sclerosis in which neurological disability worsens over time.","types":["disease course"],"aliases":["progressive MS"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_48d7a64a40c8f34a5d1450fbda3c95ad"},{"public_id":"co_5fa2f90c031434ee9b0e72f0ef5fa75d","status":"active","name":"survival","description":"The proportion of patients alive over the follow-up period.","types":["outcome"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5fa2f90c031434ee9b0e72f0ef5fa75d"},{"public_id":"co_71966efec7b61f40d3c7e6e3f0e71b9c","status":"active","name":"disease duration of 6-10 years","description":"A time interval from disease onset used for subgroup analysis.","types":["time interval"],"aliases":["6-10 yrs"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_71966efec7b61f40d3c7e6e3f0e71b9c"},{"public_id":"co_767370206fc5ce189f59fd6d7273ceb9","status":"active","name":"remitting disease","description":"Disease characterized by periods of remission rather than continuous progression.","types":["disease course"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_767370206fc5ce189f59fd6d7273ceb9"},{"public_id":"co_c0a5f24b6f7895848d78df7b92a7fd7f","status":"active","name":"40 years of follow-up","description":"The longest follow-up period mentioned for survival assessment.","types":["follow-up period"],"aliases":["up to 40 yrs"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c0a5f24b6f7895848d78df7b92a7fd7f"},{"public_id":"co_ccf9a7ea06f8b8ae1b6babdb6ee4ac44","status":"active","name":"Kurtzke Disability Status Scale","description":"A disability scale used to rate functional impairment in multiple sclerosis.","types":["measurement scale"],"aliases":["DSS"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ccf9a7ea06f8b8ae1b6babdb6ee4ac44"},{"public_id":"co_ddb4b68782a75b3a9ba7e877aa07d329","status":"active","name":"multiple sclerosis","description":"A chronic demyelinating disease of the central nervous system studied here in a longitudinal patient cohort.","types":["condition"],"aliases":["MS"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ddb4b68782a75b3a9ba7e877aa07d329"},{"public_id":"co_e145c3f911149529c4e447a0209563f0","status":"active","name":"Middlesex County subgroup","description":"The geographically based subset of patients representing most multiple sclerosis cases in Middlesex County.","types":["patient subgroup"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_e145c3f911149529c4e447a0209563f0"},{"public_id":"co_e85bdd016cd1b3220c8ba4456eaf236f","status":"active","name":"bimodal distribution of disability","description":"A disability distribution with two distinct peaks across severity levels.","types":["distribution"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_e85bdd016cd1b3220c8ba4456eaf236f"},{"public_id":"co_e96388094516e7b8f6f5e959f9a41ecb","status":"active","name":"clinical course","description":"The pattern of disease progression or remission over time.","types":["clinical feature"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_e96388094516e7b8f6f5e959f9a41ecb"},{"public_id":"co_fecad58642665f665264ef98bc34c784","status":"active","name":"DSS 6","description":"A Kurtzke Disability Status Scale level indicating that assistance is required for walking.","types":["measurement level"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_fecad58642665f665264ef98bc34c784"}],"external_ids":{"DOI":"10.1093/BRAIN/112.1.133","ArXiv":null,"PubMed":2917275,"PubMedCentral":null,"MAG":1975104912,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://academic.oup.com/brain/article-pdf/112/1/133/1042303/112-1-133.pdf","landing_url":"https://www.semanticscholar.org/paper/d348549cf1ca63132ca2791a84265c1853b244aa","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":null,"status":"BRONZE","reason":null},"reference_availability":{"status":"unknown","references_indexed":false,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631892,"paper_uid":"69e8ff6e-e2af-4795-afae-0da58993c0ca","canonical_identity":{"paper_id":631892,"paper_uid":"69e8ff6e-e2af-4795-afae-0da58993c0ca","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/6101497"}